Helping Children Receive an Earlier Autism Diagnosis

Earlier Diagnosis + Earlier Intervention = Better Outcomes

A NEW DIAGNOSTIC TOOL

Our NPDX AA test may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

Posters & Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]

Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018. NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States.[…]

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes [Biological Psychiatry, 2018]

Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder ASD is currently diagnosed based on behavioral characteristics exhibited by an affected child. While specialist clinicians are able to confidently diagnose children as young as 24 months, the average age of diagnosis in the United States is over[…]

NEWS

NeuroPointDX Names E. Robert Wassman, M.D. as Medical Director

Clinician and leader in development of personalized medicine approaches to autism spectrum disorder and other neurodevelopmental conditions MADISON, Wis.–(BUSINESS WIRE)–NeuroPointDX, a division of Stemina Biomarker Discovery, today announced the appointment of E. Robert Wassman, M.D. as Medical Director. Dr. Wassman has pioneered the introduction of personalized medicine approaches and the delivery of cutting-edge diagnostic technology[…]

  • RT @AtlanticLab: Using mass spectrometry to look at metabolic subtypes for autism spectrum disorder. Recently completed largest metabolomic…
  • Speaker, author, and autism advocate Temple Grandin urged audiences at Vanderbilt University to embrace neurodivers… https://t.co/iomuQFXV2n
  • Metabolomics is the study of small molecules, called metabolites, found in our cells, fluids, or tissues; it is the… https://t.co/SN8tBNTrBh